Ishiguro Satoshi, Iwabuchi Hiroaki, Isobe Naoki, Kawabe Atsushi, Yamasaki Seiji, Yamamoto Tsuyoshi
Dept of Surgery, Murakami Memorial Hospital, Asahi University, School of Dental Medicine.
Gan To Kagaku Ryoho. 2004 Aug;31(8):1233-5.
A 56-year-old gastric cancer patient with multiple lung metastases and dilated cardiomyopathy was treated by chemotherapy with TS-1. This case was judged to be unresectable. TS-1 (100 mg/body/day) was orally administered for 4 weeks followed by a drug-free 2-week period as 1 course. At the completion of 3 courses, the multiple lung metastases were assessed to show a complete response (CR). There were no side effects and no hospitalization. This chemotherapy is being continued, and a CR in the lung and no change of the gastric cancer have been maintained for 15 months (10 courses).
一名56岁的胃癌患者,伴有多发肺转移和扩张型心肌病,接受了替吉奥(TS-1)化疗。该病例被判定为不可切除。替吉奥(100mg/体/天)口服4周,随后停药2周作为1个疗程。3个疗程结束后,评估显示多发肺转移完全缓解(CR)。无副作用且无需住院。目前该化疗仍在继续,肺部保持CR状态,胃癌无变化已维持15个月(10个疗程)。